Skip to main content

Table 4 Differences between subjects with psoriasis with or without MS

From: Metabolic syndrome and its components in patients with psoriasis

 

MS

No MS

P

Mean ± SD

Mean ± SD

Median (minimal-maximal values)

Median (minimal-maximal values)

Age (years)

55.45 ± 11.28

42.69 ± 13.16

<0.001

BMI (kg/m2)

30.5 (22.5-41.79)

25.52 (18.9-36.36)

<0.001

HOMA Index

3.79 (1.07-22.73)

1.94 (0.85-6.97)

<0.001

Age at time of diagnosis (years)

34.25 ± 16.29

24.6 ± 13.5

0.002

Time of evolution (years)

20 (0.5-55)

15 (1-51)

ns

PASI Index

6.95 (0-35)

4.8 (0-36.3)

ns

Moderate - Severe Psoriasis

24/53 (45.2%)

18/48 (36.7%)

ns

Psoriatic Arthritis (%)

22.64%

18.3%

ns

Topical corticosteroids

54.71%

71.4%

 

Immunosupressors

4 methotrexate

1 leflunamide

 

1 methotrexate + deflazacort

 

Biolological treatment

-

2 adalimumab

  1. BMI: body mass index. PASI Psoriasis Area and Severity Index.